PUBLISHER: The Business Research Company | PRODUCT CODE: 1532005
PUBLISHER: The Business Research Company | PRODUCT CODE: 1532005
Lupus Therapeutics Global Market Report 2024
Lupus therapeutics encompass treatments and medications specifically designed to manage and alleviate the symptoms of lupus, an autoimmune disease in which the body's immune system attacks its own tissues, causing inflammation and damage in various organs. These treatments aim to reduce inflammation, suppress the overactive immune response, and improve patients' quality of life.
The primary types of lupus therapeutics include systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, neonatal lupus, and others. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects various organs and tissues, characterized by inflammation and damage to these organs. Treatments for lupus include non-steroidal anti-inflammatory drugs (NSAIDs), biologics, antimalarial drugs, corticosteroids, and others. These drugs can be administered orally, subcutaneously, intravenously, and by other methods, and are used in various settings, such as hospitals and clinics, diagnostic laboratories, and others.
The lupus therapeutics research report is one of a series of new reports from The Business Research Company that provides lupus therapeutics market statistics, including the lupus therapeutics industry's global market size, regional shares, competitors with a lupus therapeutics market share, detailed lupus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the lupus therapeutics industry. This lupus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lupus therapeutics market size has grown strongly in recent years. It will grow from $2.53 billion in 2023 to $2.74 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth during the historic period can be attributed to the increased prevalence of lupus, higher investment in healthcare infrastructure, high disposable income, strong demand for effective therapies, and the rising geriatric population.
The lupus therapeutics market size is expected to see strong growth in the next few years. It will grow to $3.83 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The anticipated growth can be attributed to increasing drug approvals and launches, emerging markets, improvements in disease awareness and diagnosis, rising awareness initiatives, and immunosuppressive products. Major trends during the forecast period include chimeric antigen receptor T-cell (CAR-T) therapy, small molecule therapeutics for lupus, CAR-NK therapy for lupus, combined inhibition of human plasmacytoid dendritic cell activity during systemic lupus erythematosus (SLE), and urine proteomics.
The growth of the lupus therapeutics market is expected to be propelled by increasing research and development activities. These activities encompass systematic investigation and experimentation aimed at advancing knowledge, technology, or product development across various fields. They are driven by the need for innovation, technological advancements, addressing emerging challenges, improving healthcare outcomes, and fostering economic growth through scientific and technological breakthroughs. Research and development efforts contribute to advancing lupus therapeutics by discovering new treatments, enhancing existing therapies, and deepening understanding of the disease's underlying mechanisms. For instance, a March 2023 report from the Congressional Research Service highlighted that the national institutes of health received $49.183 billion in 2023 for research and development activities, marking an increase from $42.941 billion allocated in 2021. This funding underscores the growing commitment to advancing medical research, including efforts related to lupus therapeutics, thereby driving market growth.
In the lupus therapeutics market, major companies are focused on developing advanced blood tests incorporating predictive artificial intelligence to improve diagnostic accuracy and treatment efficacy. These blood tests utilize AI algorithms to analyze biomarkers in blood samples, predicting disease outcomes or treatment responses more accurately. For example, AMPEL BioSolutions LLC, a US-based precision medicine company, launched the LuGENE blood test in March 2024. This innovative test predicts lupus flares and identifies drug targets through gene expression analysis with predictive AI. It aims to revolutionize lupus management by offering personalized treatment options based on real-time abnormalities in gene expression linked to inflammation and immune dysfunction.
In April 2024, Takeda Pharmaceutical Company Limited, a Japan-based biotechnology firm, acquired Nimbus Therapeutics' TYK2 program from Nimbus Lakshmi Inc. This strategic acquisition enhances Takeda's position in the immunology market and expands its portfolio of treatments for immune-mediated diseases, including lupus. Nimbus Lakshmi Inc., based in the US, specializes in developing drugs for various conditions, including lupus and psoriasis.
Major companies operating in the lupus therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca PLC, Novartis AG, Roche Holdings Inc., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Ltd, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited
North America was the largest region in the lupus therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lupus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lupus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lupus therapeutics market consists of revenues earned by entities by providing services such as autoantibody testing, anti-phospholipid antibody testing, and rheumatoid factor testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The lupus therapeutics market also includes sales of calcineurin inhibitors, immunosuppressants, anticoagulants, and antimalarial drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lupus Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lupus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lupus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lupus therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Disease Type: Systemic Lupus Erythematosus (SLE); Cutaneous Lupus Erythematosus; Drug-Induced Lupus Erythematosus; Neonatal Lupus
- 2) By Treatment Type: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs); Biologics; Antimalarial Drugs; Corticosteroids; Other Treatment Types
- 3) By Route Of Administration: Oral; Subcutaneous; Intravenous; Other Routes Of Administration
- 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Other End Users
- Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Sanofi SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lupus Therapeutics Market Characteristics
3. Lupus Therapeutics Market Trends And Strategies
4. Lupus Therapeutics Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Lupus Therapeutics Market Size and Growth
- 5.1. Global Lupus Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Lupus Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Lupus Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Lupus Therapeutics Market Segmentation
- 6.1. Global Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Systemic Lupus Erythematosus (SLE)
- Cutaneous Lupus Erythematosus
- Drug-Induced Lupus Erythematosus
- Neonatal Lupus
- 6.2. Global Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Biologics
- Antimalarial Drugs
- Corticosteroids
- Other Treatment Types
- 6.3. Global Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Oral
- Subcutaneous
- Intravenous
- Other Routes Of Administration
- 6.4. Global Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Hospitals And Clinics
- Diagnostic Laboratories
- Other End Users
7. Lupus Therapeutics Market Regional And Country Analysis
- 7.1. Global Lupus Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Lupus Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Lupus Therapeutics Market
- 8.1. Asia-Pacific Lupus Therapeutics Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Lupus Therapeutics Market
- 9.1. China Lupus Therapeutics Market Overview
- 9.2. China Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Lupus Therapeutics Market
- 10.1. India Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Lupus Therapeutics Market
- 11.1. Japan Lupus Therapeutics Market Overview
- 11.2. Japan Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Lupus Therapeutics Market
- 12.1. Australia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Lupus Therapeutics Market
- 13.1. Indonesia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Lupus Therapeutics Market
- 14.1. South Korea Lupus Therapeutics Market Overview
- 14.2. South Korea Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Lupus Therapeutics Market
- 15.1. Western Europe Lupus Therapeutics Market Overview
- 15.2. Western Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Lupus Therapeutics Market
- 16.1. UK Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Lupus Therapeutics Market
- 17.1. Germany Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Lupus Therapeutics Market
- 18.1. France Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Lupus Therapeutics Market
- 19.1. Italy Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Lupus Therapeutics Market
- 20.1. Spain Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Lupus Therapeutics Market
- 21.1. Eastern Europe Lupus Therapeutics Market Overview
- 21.2. Eastern Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Lupus Therapeutics Market
- 22.1. Russia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Lupus Therapeutics Market
- 23.1. North America Lupus Therapeutics Market Overview
- 23.2. North America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Lupus Therapeutics Market
- 24.1. USA Lupus Therapeutics Market Overview
- 24.2. USA Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Lupus Therapeutics Market
- 25.1. Canada Lupus Therapeutics Market Overview
- 25.2. Canada Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Lupus Therapeutics Market
- 26.1. South America Lupus Therapeutics Market Overview
- 26.2. South America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Lupus Therapeutics Market
- 27.1. Brazil Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Lupus Therapeutics Market
- 28.1. Middle East Lupus Therapeutics Market Overview
- 28.2. Middle East Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Lupus Therapeutics Market
- 29.1. Africa Lupus Therapeutics Market Overview
- 29.2. Africa Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Lupus Therapeutics Market Competitive Landscape And Company Profiles
- 30.1. Lupus Therapeutics Market Competitive Landscape
- 30.2. Lupus Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Merck & Co. Inc.
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Sanofi SA
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc.
31. Lupus Therapeutics Market Other Major And Innovative Companies
- 31.1. AstraZeneca PLC
- 31.2. Novartis AG
- 31.3. Roche Holdings Inc.
- 31.4. GlaxoSmithKline plc
- 31.5. Eli Lilly and Company
- 31.6. Viatris Inc.
- 31.7. Teva Pharmaceutical Industries Ltd.
- 31.8. Bausch Health Companies Inc.
- 31.9. Sun Pharmaceutical Industries Ltd.
- 31.10. Aurobindo Pharma
- 31.11. Dr. Reddy's Laboratories Ltd.
- 31.12. Hikma Pharmaceuticals PLC
- 31.13. Amneal Pharmaceuticals LLC
- 31.14. Lupin Ltd
- 31.15. Zydus Lifesciences Limited
32. Global Lupus Therapeutics Market Competitive Benchmarking
33. Global Lupus Therapeutics Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Lupus Therapeutics Market
35. Lupus Therapeutics Market Future Outlook and Potential Analysis
- 35.1 Lupus Therapeutics Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Lupus Therapeutics Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Lupus Therapeutics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
